Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/24445038
Conclusion of this study
These results are associated with reduced levels of homeostasis model assessment-insulin resistance, triglyceride, uric acid, visceral fat and total body fat. In summary, a 6-month curcumin intervention in type 2 diabetic population lowered the atherogenic risks. In addition, the extract helped to improve relevant metabolic profiles in this high-risk population.
Supplements analyzed in this study
Health conditions analyzed in this study
No health conditions information for this study.
Functions related to this study
Body systems related to this study
